Alpha-Gal Symptoms

Reactions to alpha-gal syndrome (AGS) — the red-meat allergy triggered by certain tick bites — span an unusually wide clinical range. Most patients first encounter the syndrome through skin and digestive symptoms: "Eighty to 90% of patients with AGS present with a "cutaneous phenotype" comprised of urticaria, angioedema, and pruritus in conjunction with symptoms in other organ systems, frequently the gastrointestinal (GI) tract in ~ 70%." (PMC 2025) In plain terms, that means urticaria (hives — raised itchy welts), angioedema (deeper swelling under the skin, often around the lips, eyes, or throat), and pruritus (intense itching), together with stomach or bowel symptoms in roughly seven out of ten cases. At the severe end, reactions are "often severe and sometimes fatal" (FrontCellInfectMicrobiol 2021). One review described the spectrum bluntly: "Clinical presentation ranges from hives to anaphylaxis" (CDC 2022), with "hives, swelling of the face or facial features, shortness of breath, abdominal pain, gastrointestinal issues, anaphylaxis, or even fatality" (PMC 2024) all in play. At one end, patients report nothing more than itching or a rash.

The breadth of presentation is part of what makes the syndrome so hard to recognize. As one 2024 information-seeking analysis observed, "Symptom variety remains one of the major reasons alpha-gal remains underdiagnosed. Health care professionals should not only be familiar with the most commonly identifiable symptoms of alpha-gal such as urticaria or anaphylaxis but also be knowledgeable about symptom manifestations like joint pain, gastrointestinal symptoms, dizziness, or heart palpitations." (PMC 2024)

For a primer on what alpha-gal syndrome is and how it develops, see Alpha-Gal Syndrome: What It Is and How a Tick Bite Rewrites Your Diet.

What Symptoms Does Alpha-Gal Syndrome Cause?

The severity range in alpha-gal syndrome stretches from localized skin symptoms to cardiovascular collapse — meaning a sudden drop in blood pressure that can be fatal. Clinical experience across thousands of patients has produced a detailed, if sobering, picture. A review based on a clinic-based cohort of 2,500 patients distilled the most common pattern: reactions "range from pruritus, localized hives or angioedema to anaphylaxis" (T&F 2020), and patients can "report strictly gastrointestinal symptoms (diarrhea, abdominal cramping, emesis) almost to the exclusion of cutaneous, cardiovascular or respiratory manifestations" (T&F 2020). Emesis is the medical word for vomiting. A 2018 HHS Tick-Borne Disease Working Group report to Congress summarized the standard textbook picture: reactions "can present with rash-like (urticarial), gastrointestinal symptoms, and airway obstruction (angioedema). Fatalities are rarely seen, but it can be life-threatening with anaphylaxis." (HHS 2018)

The clinical picture continues to expand beyond what textbooks would predict. The 2024 HHS scoping review noted that "This condition has been increasingly recognized for its diverse clinical manifestations, and a noteworthy case has brought attention to the potential for chronic periorbital edema as an unusual presentation of AGS." (HHS 2024) Periorbital edema means long-lasting swelling of the tissue around the eyes. A 2023 concise review reported researchers had published "AGS presenting as erythrodermic psoriasis that cleared-up rapidly with mammalian-product exclusion" (MDPI 2023) — a severe, widespread skin condition called erythrodermic psoriasis that resolved when patients stopped eating mammal products — and had "also related AGS and fibromyalgia in a series of American Indian patients, resolving with mammalian-product elimination" (MDPI 2023). Fibromyalgia is a chronic condition marked by widespread muscle pain and fatigue with no clear structural cause.

Alpha-gal-associated symptoms may also mimic rheumatologic disease — that is, joint and connective-tissue conditions like rheumatoid arthritis. A cross-sectional study from Johnston County, North Carolina, found that "only α-gal IgE was associated with knee pain, aching, or stiffness (mean ratio, 1.30; 95% CI, 1.09–1.56)" (MDPI 2023). A separate 2025 review confirmed the association: "Recent data have also linked AG IgE to the presence of certain chronic musculoskeletal symptoms. For example, a study performed in a population in which 17.5% had an AG IgE level of >0.1 IU/mL found that AG sensitization was associated with knee pain, aching, or stiffness, while antibodies to Ehrlichia and Rickettsia were not." (PMC 2025) Joint pain is also among the conditions described by Commins and colleagues, who noted that "Other conditions that also arise less commonly, and may not be causally related to AGS, include joint pain and chronic pruritus." (T&F 2020) The same review reported early, preliminary observations of "the formation of several autoantibodies without full-blown systemic inflammatory immune-mediated rheumatic diseases in patients with AGS" (MDPI 2023). Autoantibodies are antibodies that mistakenly attack the body's own tissues.

Can You Get Hives or Skin Symptoms from Alpha-Gal?

The most common presentation involves the skin and the moist linings of the mouth, eyes, and airway — what doctors call the mucocutaneous surfaces. A separate 2020 review of pediatric and adult cohorts confirmed the picture: "cutaneous symptoms characterized by urticaria, angioedema, and pruritus are the presenting symptoms for 80–90% of individuals with alpha-gal syndrome, followed by anaphylaxis (60%)." (PMC 2020) In plain terms, the great majority of patients show urticaria (hives — raised itchy welts), angioedema (deeper swelling under the skin, often around the lips, eyes, or throat), and pruritus (intense itching), together with stomach or bowel symptoms in roughly seven out of ten cases.

A CDC clinical study confirmed that "Mucocutaneous signs and symptoms (n = 87, 87%) were the most common, with hives/urticaria (n = 68, 68%) being the most frequently reported overall" (CDC 2022). A small transcriptional-profiling cohort showed a similar distribution: "Of the 15 participants with AGS, 93% reported cutaneous symptoms, 73% gastrointestinal symptoms, and 33% or less described respiratory, oropharyngeal, or cardiovascular symptoms." (PMC 2022) Oropharyngeal refers to the mouth and upper throat. A Swedish cohort cited in the same review found "90% had urticaria, 74% had gastrointestinal symptoms, and 50% had anaphylaxis" (PMC 2022).

Distinguishing alpha-gal from other chronic skin conditions can also be difficult; one review observed that "Distinguishing AGS from chronic spontaneous urticaria (CSU) can be challenging, leading to misdiagnosis and, in some cases, the two entities may overlap." (T&F 2020) At the mildest end of the spectrum, "<1% of patients have reported isolated itching in the mouth or swelling of the tongue" (T&F 2020).

Can You Get Stomach Pain or Diarrhea from Alpha-Gal?

As one infectious-diseases review put it, "Unexpectedly, having gastrointestinal symptoms appears to be the most common clinical presentation. Consequently, many patients are initially incorrectly diagnosed with irritable bowel syndrome." (PMC 2025)

The catalog of digestive complaints is broad. CDC clinical research described "abdominal pain, nausea, vomiting, and diarrhea" (CDC 2022) as the typical pattern, and a 2022 review listed "urticaria, angioedema, respiratory distress, emesis, diarrhea, reflux, and abdominal pain" (PMC 2022) among the spectrum. Patients describe pain that is often hard to localize: in one retrospective gastroenterology cohort, "Patient descriptions of abdominal pain varied from generalized epigastric to smaller incidences in the left or right quadrants, periumbilical, and suprapubic areas." (PMC 2025) Epigastric refers to the upper-middle area of the abdomen, just below the breastbone. The CDC has summarized the picture in plain language for clinicians: AGS "Symptoms range from mild (e.g., a rash or gastrointestinal upset) to severe (anaphylaxis)" (CDC 2023).

A 2022 review captured why GI symptoms in particular get missed: "Gastrointestinal symptoms were also commonly reported, which is notable as patients and providers may overlook abdominal pain and cramping as a feature of an allergic reaction, underappreciating the systemic response to alpha-gal." (CDC 2022)

Can Alpha-Gal Cause Symptoms Without Rash or Hives?

A significant subset of patients experience severe digestive distress — sometimes without any visible skin reaction at all. One review described this as a distinct pattern of disease:

"A gastrointestinal-predominant form of alpha-gal syndrome has also emerged, affecting approximately 20% of patients; patients describe severe, persistent abdominal cramping and diarrhea. Moreover, gastrointestinal reflux can be an early symptom, occurring within minutes to 1 hour after ingestion of mammalian products." — PMC, 2020. "Doc, Will I Ever Eat St...

In other words, about one in five patients have alpha-gal syndrome that shows up mainly as severe belly pain and diarrhea, sometimes starting within an hour of eating mammal meat or dairy. Estimates of the GI-only fraction vary across cohorts. The Commins review of 2,500 patients reported that "3-20% of patients with AGS report abdominal pain, nausea, emesis, diarrhea, heartburn in isolation of cutaneous, cardiovascular or other signs/symptoms" (T&F 2020). A 2025 effector-cell review put the range higher in some populations: "Fifteen to 40% present with gastrointestinal symptoms only, including emesis, gastroesophageal reflux, abdominal pain, abdominal bloating, and diarrhea." (PMC 2025)

CDC research has confirmed the GI-only phenotype directly: "A subset of patients report gastrointestinal (GI) symptoms (including abdominal pain, nausea, vomiting, and diarrhea) without mucocutaneous, respiratory, or cardiovascular symptoms." (CDC 2022) A 2025 case from Maine illustrated the picture in a single patient: "The patient's symptoms fit the GI phenotype of AGS. She did not experience hives, angioedema, respiratory difficulty, hypotension, or anaphylaxis." (CDC-EID 2025) Hypotension is abnormally low blood pressure, a danger sign in severe allergic reactions.

Can Alpha-Gal Symptoms Look Like IBS?

A 2025 review reinforced the scope of this problem: "In one US cohort more than half of patients with solely GI symptoms met criteria for diarrhea-predominant irritable bowel syndrome." (PMC 2025) A separate review captured the diagnostic confusion in a single sentence: "Symptoms commonly associated with irritable bowel syndrome (IBS), such as abdominal pain, nausea, vomiting, and diarrhea, are also associated with AGS." (PMC 2025)

Patients with mainly digestive symptoms sometimes endure unnecessary procedures before anyone considers alpha-gal. A review drawing on 2,500 patients noted that "examples of patients with AGS who have had exploratory surgery, removal of gallbladder or appendix, and partial pancreatectomy have been reported" (T&F 2020) — that last term meaning the surgical removal of part of the pancreas. A first-person account from one of the authors of a 2025 narrative review tracks the typical workup:

"One of the authors (S.P.) of this review spent two years exploring possible causes of abdominal pain, diarrhea, and nausea without any clinical suspicion that the disease was AGS. Prior to a definitive diagnosis, the author underwent endoscopy and colonoscopy procedures, was diagnosed with IBS, and received little-to-no relief from prescribed anti-spasmodic and anti-inflammatory drugs. After an official diagnosis via a positive blood serum test for the presence of alpha-gal–specific IgE antibodies, the author was able to achieve full resolution of symptoms by adhering to an alpha-gal–free diet, including avoidance of beef, lamb, pork, dairy, magnesium stearate, and carrageenan." — PMC, 2025. Alpha-gal syndrome and th...

The IBS overlap is not merely theoretical — it shows up in measurable numbers when clinicians look. A retrospective review at a community gastroenterology practice in the southeastern U.S. illustrates the scale: "of 1112 adult patients with gastrointestinal symptoms, 32.3% (359) had detectable circulating alpha-gal IgE. Of the 122 patients with follow-up data available for analysis, 82% reported improvement of symptoms reminiscent of irritable bowel syndrome following removal of red (mammalian) meat from the diet." (PMC 2022) The 2025 narrative review reported related figures from a separate retrospective cohort: "359 patients (32.3%) tested positive for serum IgE to alpha-gal, and 270 (24.3%) stated their main complaint was abdominal symptoms such as pain, nausea, diarrhea, and vomiting" (PMC 2025), and noted that "19 patients in this study were previously diagnosed with IBS, and of those, 14 tested positive for alpha-gal–specific IgE antibodies." (PMC 2025) Among patients placed on an alpha-gal-free diet, "82% reported improvement of their GI symptoms." (PMC 2025)

A small North Carolina chart review found that the most common gastrointestinal symptoms in alpha-gal IgE-positive patients were "abdominal pain (87.5%), nausea (75%), and diarrhea (68.75%) without accompanying skin, respiratory, or circulatory symptoms." (PMC 2025) The takeaway for clinicians is direct: "clinicians, especially those practicing in the Lone Star tick habitat, should consider AGS in cases of GI symptoms of unknown etiology, even in the absence of skin and respiratory allergy symptoms." (PMC 2025)

Do Children with Alpha-Gal Have the Same Symptoms as Adults?

The clinical picture in children largely mirrors adults, but with some distinctive emphases. The gastrointestinal presentation is especially prominent: research has found that "AGS predominantly manifests as isolated gastrointestinal symptoms in the pediatric population" (HHS 2024). A 2025 narrative review reported that "Among pediatric patients exhibiting delayed red-meat allergy, two studies reported a prevalence of GI symptoms of 64% and 66% in combination with other AGS reactions such as urticaria and angioedema with or without anaphylaxis. In a retrospective investigation of 199 pediatric patients, Busing et al. reported that 20.1% tested positive for alpha-gal and presented with only GI symptoms." (PMC 2025)

A pediatric vignette from rural Missouri illustrates how the GI-only phenotype can lead to extensive — and unrevealing — workups before alpha-gal is considered:

"“Ben” is an 11-year-old boy referred to the psychiatric clinic by his pediatrician after experiencing years of gastrointestinal symptoms, including nausea, diarrhea, and episodic stomach pains. Workup including upper gastrointestinal endoscopy and colonoscopy was unrevealing and conservative management has failed. He has been missing school due to his symptoms and the school district is concerned about truancy. He lives in rural Missouri with his family who manages a tight budget, saving money by purchasing half of a steer or a whole hog at a time to feed the family. Ben is a picky eater, preferring meat with most meals." — PsychT, 2024. Climate Change, Vector Ra...

One review noted that "Although published data suggest that the condition in children has similar features to those of adult patients, it is not unusual for children with AGS to report a specific association with limited number of foods, predominance of GI symptoms and particular relevance of activity (e.g., sports practice)." (T&F 2020) A pediatric chart review from southwest Missouri painted a more granular picture: "the average age of diagnosis among pediatric patients was 9.95 years with most presenting with urticaria and angioedema (99%) followed by anaphylaxis (29%) and gastrointestinal symptoms (17%)." (PMC 2020) An earlier case series detected "alpha-gal specific IgE in nearly 90% of these children" (PMC 2020) who reported delayed urticaria (hives), angioedema (deep swelling), or anaphylaxis after eating mammalian meat.

A general anaphylaxis-management guideline notes that age shifts the symptom mix in non-AGS allergic reactions as well: "Children typically present with more cutaneous and respiratory symptoms than adults, and adults present with more of these symptoms than the elderly. Elderly patients appear to have more cardiovascular symptoms than adults, and these symptoms are more common in adults than in children." (FrontPharmacol 2022)

Can Alpha-Gal Cause Respiratory Symptoms Like Wheezing?

Respiratory symptoms occur in alpha-gal syndrome but are not among its most common presentations — and when they appear, they typically signal a more severe reaction. CDC-aligned clinical research found that "Respiratory (n = 24, 24%) or cardiovascular symptoms were less frequently reported (n = 31, 31% )." (CDC 2022) The same study observed a clinically important pattern: "Cardiovascular and respiratory symptoms were almost exclusively reported by those who objectively qualified as having a more severe outcome (anaphylaxis)." (CDC 2022) The investigators noted that this distribution is unusual for a food allergy: "The relative paucity of cardiovascular and respiratory symptoms in AGS patients represents a clinical deviation from other food allergies." (CDC 2022)

That deviation matters because respiratory and circulatory failure are the proximate mechanisms of fatal anaphylaxis. As one clinical practice guideline summarized, "Respiratory and/or cardiovascular compromise are the leading cause of death from anaphylaxis, so they are indicative of severe anaphylaxis." (FrontPharmacol 2022) A 2025 effector-cell review reinforced where AGS sits within that hierarchy: "AGS patients are more likely to report cutaneous and gastrointestinal symptoms, over respiratory, oropharyngeal, and cardiovascular symptoms." (PMC 2025)

For asthma specifically: "Patients with a history of lung disease, especially asthma, are at higher risk for morbidity and mortality, thus early intubation should be considered during their assessment." (FrontPharmacol 2022) A specific AGS+asthma case: "Our cohort of study participants with alpha-gal includes a 32-year-old woman with AGS and asthma who experienced anaphylaxis while working at a leather tanning factory and required an emergency department visit." (PMC 2022)

An occupational case series showed that respiratory symptoms can also occur outside the dinner table — three cattle workers developed "symptoms (urticaria, pruritus, and/or dyspnea) following direct contact with bovine amniotic fluid during calving" (PMC 2022) — illustrating that dyspnea (difficult or labored breathing) can arise from non-food exposures as well.

In oral food challenge studies: "Symptoms ranged from pruritus, urticaria and abdominal cramping to cough, chills, and chest tightness." (PMC 2025) Pruritus is itching; urticaria is hives. An oral food challenge is a supervised test in which a patient eats a small amount of a suspected trigger food under medical observation to confirm the allergy.

Why Do Reactions Vary in Severity from One Episode to the Next?

One of the most disorienting features of alpha-gal syndrome is that the same person can eat a steak one night with nothing more than mild discomfort and react to a smaller portion weeks later with full anaphylaxis. The difference comes down to co-factors and the form of allergen consumed, not portion size alone. A 2022 case report from Caron illustrates this same-patient variability: "After eating red meat, a 56-year-old male patient had developed symptoms such as a generalized urticaria, diarrhea, and faintness, requiring admission to the Emergency Department." (PMC 2022) A review based on 2,500 patients explained:

"An additional point is that some patients with the syndrome may tolerate mammalian meat on occasion with few or no symptoms but have severe reactions on others. This intra-individual variability is often not explained by the amount of meat consumed and may reflect differences in the quantity or form of alpha-gal that is present in the meat or, more likely, reflects the importance of co-factors such as medications, activity, alcohol consumption or recent tick bites." — T&F, 2020. Diagnosis & Management of...

Put plainly: the severity of any single reaction depends not just on how much meat was eaten but on what else is happening at the time, making any given meal hard to predict. Or, as one clinical case report summarized: "Cofactors can determine an interindividual variability and different reactions even in the same individual and are thus confounding factors." (PMC 2022)

What makes a given reaction more severe involves a constellation of factors. The form of the allergen matters — fattier cuts and organ meats carry more alpha-gal. A 2021 Frontiers in Allergy review detailed this: "consumption of fattier forms of meat and of mammalian innards, such as pork kidney, which are known to contain more α-Gal epitopes than muscle meat, can lead to more severe and rapid reactions" (FrontAllergy 2021). An epitope is the specific molecular fragment an antibody recognizes; more epitopes per bite means a stronger immune trigger. Co-factors also modulate outcomes — a 2025 review described how "Exercise, alcohol, and NSAIDs can increase intestinal barrier permeability, potentially amplifying the amount of alpha-gal allergen absorbed and trafficked to sensitized MCs and basophils." (PMC 2025) NSAIDs are common over-the-counter pain relievers like ibuprofen and naproxen; "MCs and basophils" refer to mast cells and basophils, the immune cells that release the chemicals causing allergic symptoms.

The full catalog of what sets off reactions — specific foods, products, co-factors, and dose considerations — is covered in Alpha-Gal Reaction Triggers.

A patient's broader allergy background also plays a role. One 2025 review found that "a personal history of atopy increasing the likelihood of anaphylaxis to mammalian meat ingestion" (PMC 2025). Atopy is the inherited tendency to develop allergic conditions like eczema, asthma, or hay fever. And a small proportion of patients may develop a complicating mast cell condition: "Approximately 3-5% of patients also appear to develop signs/symptoms consistent with a mast cell syndrome, which could be related to mast cell releasing factors present in tick saliva or the significant increase in total IgE leading to increased mast cell reactivity." (T&F 2020) When alpha-gal syndrome and systemic mastocytosis — a rare disease in which the body builds up too many mast cells — co-occur, the consequences are more serious: one study found that "individuals with concurrent alpha-gal syndrome and systemic mastocytosis had more severe clinical reactions after alpha-gal ingestion" (PMC 2020). A subset of patients also evolve toward what one review called "a MC hyperreactivity phenotype characterized by episodic symptoms consistent with spontaneous MC activation and degranulation" (PMC 2025) — meaning mast cells that fire on their own, even in the absence of a clear food trigger, in patients who have removed mammalian products from their diet. Degranulation is the process by which immune cells release their stored chemicals — like histamine — into the bloodstream, triggering the symptoms of an allergic reaction.

Does a High Alpha-Gal IgE Level Mean Reactions Will Be More Severe?

The clinical implication is that IgE antibody blood-test levels — IgE, or immunoglobulin E, is the antibody class that drives allergic reactions — do not serve as a reliable severity predictor. As one clinician-researcher team summarized, "The titer of alpha-gal specific IgE does not predict reaction severity; rather dose (amount consumed) and presence of co-factors (alcohol, activity) affect the delay before reaction and resulting clinical manifestations." (T&F 2020) Titer here means the measured concentration of the antibody in a blood sample. A 2025 infectious-disease review confirmed the point: "The titer of AG IgE in blood does not appear to predict AGS symptom severity." (PMC 2025)

The point bears reinforcement from a separate research group, given how often patients are told otherwise: "levels of specific IgE are not a useful biomarker for predicting the severity of allergic reactions, as AGS patients experiencing anaphylactic reactions may maintain IgE levels overtime or even in rare occasions with anti-α-Gal IgE negative results." (PMC 2022) A biomarker is a measurable substance in blood or tissue that doctors use to detect or track a disease. A 2022 review in ImmunoTargets and Therapy added that "sensitization to alpha-gal does not guarantee the presence of symptoms, and the serum IgE level is not predictive of symptoms or severity of reactions." (PMC 2022) A 2025 narrative review described how IgE levels still carry diagnostic — though not severity — meaning: in one study, an "IgE value of 2.00 kU/L was indicative of a greater than 58% probability of having a meat allergy, whereas an IgE value > 5.5 kU/L had a 95% probability" (PMC 2025), and the same study identified "two different phenotypes for alpha-gal allergic patients: one where patients react with GI symptoms only, and the other with GI distress, urticaria, rash or other severe reactions." (PMC 2025)

Can You Get Anaphylaxis from Alpha-Gal Syndrome?

Alpha-gal syndrome is not merely an inconvenient food sensitivity — it is, in specific geographic regions, a leading driver of life-threatening allergic emergencies. In the southeastern United States, "alpha-gal syndrome is a leading cause of anaphylaxis among adults and adolescents" (PMC 2022). Cases that had been called idiopathic anaphylaxis — meaning severe allergic reactions with no identified cause — turned out, in many instances, to be alpha-gal once clinicians began testing for it. A 2017 paper put it succinctly: AGS is "A well-documented food allergy, "alpha-gal," due to sensitization to the carbohydrate galactose-α-1,3-galactose, can explain some cases of idiopathic anaphylaxis." (PMC 2017)

A 2022 review described how the diagnosis reshaped one Tennessee practice's caseload:

"For instance, Pattanaik et al noted that the number of idiopathic anaphylaxis cases declined in one Tennessee practice, while numbers of AGS-associated anaphylaxis increased. Alpha-gal syndrome accounted for one-third of anaphylaxis cases in this single-center retrospective review, while idiopathic anaphylaxis cases dropped from 59% in 2006 to 35% in 2018." — PMC, 2022. The Meat of the Matter: U...

That shift is corroborated by a separate 2025 effector-cell review: "in a single academic practice in Tennessee, idiopathic anaphylaxis cases dropped from 59 to 35% over a 12-year period from 2006 to 2018 due to newly identified AGS as the etiology. In this same practice, AGS accounted for 33% of anaphylaxis cases with known cause." (PMC 2025) A Spanish urticaria (hives)-and-anaphylaxis cohort found that "the frequency of alpha-gal IgE in patients presenting with urticaria or anaphylaxis was 15%, suggesting that alpha-gal syndrome should be seriously considered in patients who present with unexplained hives, swelling, or spontaneous allergic reactions." (PMC 2022) The danger extends beyond food. When patients encounter alpha-gal through medical products delivered directly into a vein — what clinicians call intravenous (IV) administration — the reaction can be immediate and catastrophic rather than delayed. See Alpha-Gal in Medications and Medical Procedures.

Practical emergency preparedness for patients — including medical alert protocols and EpiPen guidance — is covered in Alpha-Gal Syndrome Emergency Preparedness.

How Many People with Alpha-Gal Get Anaphylaxis?

Data from a 2022 Journal of Clinical Medicine paper placed the anaphylaxis rate broadly: "Anaphylaxis has been triggered in up to 60% of AGS cases and can be fatal if it is not treated promptly." (PMC 2022) Smaller patient-reported cohorts find similar numbers: in one survey, "Seventy-one percent (20 of 28) of participants described their initial symptoms as severe." (PMC 2017) In the CDC clinical study referenced earlier, "Nearly half of patients required emergency care for an AGS reaction (n = 41, 41%) or were prescribed an epinephrine auto-injector (n = 40, 40%)." (CDC 2022) Epinephrine — also called adrenaline — is the medication used to stop a severe allergic reaction; an epinephrine auto-injector is the portable device patients carry for emergencies.

In supervised feeding tests run in the clinic, the stakes are high. Drawing on experience with 2,500 patients, one group reported that "15-20% of food challenge reactions in patients with AGS require one or more doses of epinephrine and/or emergency medical transport" (T&F 2020) — meaning the rescue medication delivered by an EpiPen. The CDC-aligned clinical study summarizing the same threshold concluded that "AGS is both a severe allergy, with nearly 75% of patients meeting criteria for anaphylaxis, and also distinct from other food allergies in its symptom profile." (CDC 2022) Earlier CDC research in the same cohort confirmed the high-severity burden: "75% met the criteria for anaphylaxis based on the involvement of ≥2 organ systems" (CDC 2022), meaning three out of four had reactions serious enough to affect at least two body systems at once — the threshold doctors use to call something anaphylaxis, a severe whole-body allergic reaction.

Sources

    Not medical advice. See a healthcare provider for medical decisions. Medical Disclaimer